Delivery Order SPE2DB20D7059-SPE2DB25FQEQ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,633.36 for Xulane 150-35 mcg/day transdermal patches (3-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,179.78 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,477.59 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xulane 150-35 mcg/day transdermal patches (3-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 3, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is executed...
- The Defense Logistics Agency awarded a $1,299.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-unit supply) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,888.42 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive transdermal patch. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.60 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package). The contract, issued on April 21, 2025, with an ultimate completion date of April 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed...
- The Defense Logistics Agency awarded a delivery order valued at $10,623.13 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY patches (a three-pack contraceptive transdermal patch). This firm fixed price, competitively awarded delivery order is scheduled for completion by September 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement executed through the agency's established...
- The Defense Logistics Agency awarded a delivery order valued at $1,983.30 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 20, 2025, with completion expected by August 21, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQEQ7Delivery Order
The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (quantity of 3 units) on April 23, 2025, with an ultimate completion date of April 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA and its Medical Supply Chain, covering diverse therapeutic domains including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This particular delivery order for XULANE contraceptive patches reflects the company's ongoing role in supplying routine pharmaceutical commodities to support military and federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 4/23/25 |